Quality of Life in Children Receiving Treatment for Mycobacterium Abscessus Otomastoiditis

Overview

Journal Clin Otolaryngol

Specialty Otorhinolaryngology

Date 2022 Mar 27

PMID 35340110

Authors

Theresa Y S Leow

Stijn Bekkers

Arno M Janssen

Sjoert A H Pegge

Henricus P M Kunst

Jerome J Waterval

Thijs T G Jansen

Stefanie S V Henriet

Koen J van Aerde

Jakko van Ingen

Myrthe K S Hol

Affiliations

Soon will be listed here.

Citing Articles

Mycobacterial Infection in Recalcitrant Otomastoiditis: A Case Series and Literature Review.

Tsai T, Lan W, Mao J, Lee Y, Tsou Y, Lin C J Clin Med. 2023; 12(23).

PMID: 38068331 PMC: 10706855. DOI: 10.3390/jcm12237279.

Quality of life in children receiving treatment for Mycobacterium abscessus otomastoiditis.

Leow T, Bekkers S, Janssen A, Pegge S, Kunst H, Waterval J Clin Otolaryngol. 2022; 47(4):529-535.

PMID: 35340110 PMC: 9314591. DOI: 10.1111/coa.13931.

References

Hendry J, Chin A, Swan I, Akeroyd M, Browning G . The Glasgow Benefit Inventory: a systematic review of the use and value of an otorhinolaryngological generic patient-recorded outcome measure. Clin Otolaryngol. 2015; 41(3):259-75. PMC: 5912499. DOI: 10.1111/coa.12518. View

Nessar R, Cambau E, Reyrat J, Murray A, Gicquel B . Mycobacterium abscessus: a new antibiotic nightmare. J Antimicrob Chemother. 2012; 67(4):810-8. DOI: 10.1093/jac/dkr578. View

Leow T, Bekkers S, Janssen A, Pegge S, Kunst H, Waterval J . Quality of life in children receiving treatment for Mycobacterium abscessus otomastoiditis. Clin Otolaryngol. 2022; 47(4):529-535. PMC: 9314591. DOI: 10.1111/coa.13931. View

Czaja C, Levin A, Cox C, Vargas D, Daley C, Cott G . Improvement in Quality of Life after Therapy for Mycobacterium abscessus Group Lung Infection. A Prospective Cohort Study. Ann Am Thorac Soc. 2015; 13(1):40-8. DOI: 10.1513/AnnalsATS.201508-529OC. View

Kunst S, Hol M, Cremers C, Mylanus E . Bone-anchored hearing aid in patients with moderate mental retardation: impact and benefit assessment. Otol Neurotol. 2007; 28(6):793-7. DOI: 10.1097/MAO.0b013e31809ed93a. View

Lee M, Sheng W, Hung C, Yu C, Lee L, Hsueh P . Mycobacterium abscessus Complex Infections in Humans. Emerg Infect Dis. 2015; 21(9):1638-46. PMC: 4550155. DOI: 10.3201/2109.141634. View

Kubba H, Swan I, Gatehouse S . The Glasgow Children's Benefit Inventory: a new instrument for assessing health-related benefit after an intervention. Ann Otol Rhinol Laryngol. 2005; 113(12):980-6. DOI: 10.1177/000348940411301208. View

Yeh C, Tu T, Wang M, Chu C, Huang C, Su W . Emergence of Refractory Otomastoiditis Due to Nontuberculous Mycobacteria: Institutional Experience and Review of the Literature. Clin Infect Dis. 2015; 62(6):739-745. DOI: 10.1093/cid/civ1033. View

van Wijk F, Waterval J, van Aerde K, Henriet S, Anton Meijer F, Borra L . Successful Systemic and Topical Treatment of Mycobacterium abscessus Otomastoiditis. Antimicrob Agents Chemother. 2019; 64(1). PMC: 7187624. DOI: 10.1128/AAC.01203-19. View

10.

De Greve G, van Dinther J, Maryn Y, Vanspauwen R, Zarowski A, Offeciers E . Validity and Test-Retest Reliability of the Dutch Version of the Chronic Otitis Media Benefit Inventory. J Int Adv Otol. 2019; 15(1):34-37. PMC: 6483420. DOI: 10.5152/iao.2019.6339. View

11.

Schwentner I, Schwentner C, Schmutzhard J, Radmayr C, Grabher G, Sprinzl G . Validation of the German Glasgow children's benefit inventory. J Eval Clin Pract. 2007; 13(6):942-6. DOI: 10.1111/j.1365-2753.2006.00823.x. View

12.

McDermott A, Williams J, Kuo M, Reid A, Proops D . Quality of life in children fitted with a bone-anchored hearing aid. Otol Neurotol. 2008; 30(3):344-9. DOI: 10.1097/MAO.0b013e31818b6491. View

13.

Kwak N, Kim S, Choi S, Lee J, Lee C, Yim J . Longitudinal changes in health-related quality of life according to clinical course among patients with non-tuberculous mycobacterial pulmonary disease: a prospective cohort study. BMC Pulm Med. 2020; 20(1):126. PMC: 7203799. DOI: 10.1186/s12890-020-1165-3. View